Media briefing: Psychedelic drug therapies


"Some U.S. states are legalizing, decriminalizing, or funding research into therapeutic uses of psilocybin and other psychedelic drugs. Several others are considering doing so. SciLine’s media briefing covered the latest research on uses of psychedelics to manage post-traumatic stress disorder (PTSD), addiction, and depressive disorders, as well as the risks, barriers, and potential for misuse of psychedelic drug therapies. Three panelists made brief presentations and then took questions on the record."


SciLine, American Association for the Advancement of Science (AAAS)


August 16, 2023